None listed
Conditions
Interventions
Drug : Experimental Group, Sufentanil Group (Group S): Prepare Sufentanil 50 mcg/cc by diluting it in normal saline 49 cc to achieve a concentration of 1 mcg/cc, totaling 50 cc in a syringe. Administe
Sponsors
Chung-Ang University Gwangmyeong Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Adult female patient with American Society of Anesthesiologists physical status level 1-2 scheduled for breast-conserving surgery under general anesthesia
Exclusion criteria
Exclusion criteria: - Under 18 years of age or over 70 years of age - ASA 3 or higher - BMI 35 or higher - Pregnant and lactating women - Patients with serious cardiovascular, liver, kidney, and hematological abnormalities - Patients with uncontrolled respiratory disease and moderate to severe pulmonary dysfunction - Those taking opioids, anticonvulsants, or antidepressants - Those with a history of hypersensitivity or serious side effects to drugs related to this study (opioids, acetaminophen, tramadol) - During the surgical procedure, the scope of surgery is reduced to a tumor resection or expanded to a total mastectomy. - Those who refused to participate in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Opioid consumption during 24 hours after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain score (11-point NRS) at 30 minutes, 6 hours, 24 hours, and 48 hours after surgery, presence of nausea and vomiting, number of antiemetic drugs administered after surgery | — |
Countries
Korea, Republic of
Contacts
Public Contactmin kyoung kim
Chung-Ang University
Outcome results
None listed